Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - GlaxoSmithKline: 'Future Ready' For Genomic Medicine

PFE - GlaxoSmithKline: 'Future Ready' For Genomic Medicine

Pfizer Inc.
  • The largest pharmaceutical companies in the world are restructuring.  Biopharma represents a far more valuable future than growth-dilutive consumer health revenues.
  • GSK cleared room for next generation oncology cellular medicines by selling their prior portfolio to Novartis.  This provided capital to invest in new approach R&D and supply chain technology.
  • GSK is currently a buy based upon a sub-teen earnings multiple, dividend payout ratio and 5.4% yield while waiting for investments in genomic medicine to bear fruit.

For further details see:

GlaxoSmithKline: 'Future Ready' For Genomic Medicine
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...